|
Characteristics
|
n
|
Low
|
High
|
High positive rate (%)
|
P-value
|
|---|
|
(−)
|
(+)
|
(++)
|
(+++)
|
|---|
|
FIGO stage
|
0.006*
|
|
I–II
|
35
|
6
|
9
|
8
|
12
|
57.14
|
|
III–IV
|
46
|
2
|
5
|
21
|
18
|
84.78
|
|
Differentiation
|
0.401
|
|
Well–moderate
|
38
|
3
|
9
|
13
|
13
|
68.42
|
|
Poor
|
43
|
5
|
5
|
16
|
17
|
76.74
|
|
LN metastasis
|
0.414
|
|
No
|
45
|
6
|
8
|
15
|
16
|
68.89
|
|
Yes
|
19
|
0
|
4
|
8
|
7
|
78.95
|
|
No lymphadenectomy
|
17
|
2
|
2
|
6
|
7
|
76.47
|
|
Pathologic type
|
0.673
|
|
Serous
|
40
|
3
|
8
|
15
|
14
|
72.50
|
|
Mucinous
|
9
|
1
|
3
|
3
|
2
|
55.56
|
|
Endometrioid
|
11
|
2
|
1
|
3
|
5
|
72.72
|
|
Clear cell carcinoma
|
8
|
0
|
1
|
2
|
5
|
87.50
|
|
Poorly differentiated adenocarcinoma
|
13
|
2
|
1
|
6
|
4
|
76.92
|
- FIGO International Federation of Gynecology and Obstetrics, LN lymph node
- * P < 0.05
